{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T20:01:32Z","timestamp":1781726492400,"version":"3.54.5"},"reference-count":151,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.blre.2022.101029","type":"journal-article","created":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T19:56:39Z","timestamp":1668023799000},"page":"101029","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Molecular basis of rare congenital bleeding disorders"],"prefix":"10.1016","volume":"59","author":[{"given":"Akbar","family":"Dorgalaleh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehran","family":"Bahraini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmood","family":"Shams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fereshteh","family":"Parhizkari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Dabbagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tohid","family":"Naderi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aysan","family":"Fallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alieh","family":"Fazeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Esmaeil","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Samii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Daneshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farshad","family":"Heydari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shadi","family":"Tabibian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behnaz","family":"Tavasoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Noroozi-Aghideh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahere","family":"Tabatabaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Saeed","family":"Gholami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.blre.2022.101029_bb0005","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1080\/10245332.2016.1263007","article-title":"Diagnosis, clinical manifestations and management of rare bleeding disorders in Iran","volume":"22","author":"Dorgalaleh","year":"2017","journal-title":"Hematology"},{"key":"10.1016\/j.blre.2022.101029_bb0010","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.thromres.2019.07.014","article-title":"The use of prophylaxis in the treatment of rare bleeding disorders","volume":"196","author":"Shapiro","year":"2020","journal-title":"Thromb Res"},{"issue":"1","key":"10.1016\/j.blre.2022.101029_bb0015","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1055\/s-0038-1676580","article-title":"A unique factor XIII mutation in southeastern Iran with an unexpectedly high prevalence: khash factor XIII","volume":"45","author":"Dorgalaleh","year":"2019","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.blre.2022.101029_bb0020","article-title":"Gastrointestinal bleeding in congenital bleeding disorders","author":"Samii","year":"2022","journal-title":"Semin Thromb Hemost"},{"issue":"08","key":"10.1016\/j.blre.2022.101029_bb0025","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1080\/17474086.2020.1796622","article-title":"Pharmacological management of rare coagulation factor deficiencies besides hemophilia","volume":"13","author":"Dorgalaleh","year":"2020","journal-title":"Expert Rev Hematol"},{"issue":"04","key":"10.1016\/j.blre.2022.101029_bb0030","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1538-7836.2012.04653.x","article-title":"Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders","volume":"10","author":"Peyvandi","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2022.101029_bb0035","doi-asserted-by":"crossref","first-page":"e195","DOI":"10.1111\/j.1365-2516.2011.02730.x","article-title":"Correlating clinical manifestations with factor levels in rare bleeding disorders: a report from southern India","volume":"18","author":"Viswabandya","year":"2012","journal-title":"Haemophilia"},{"key":"10.1016\/j.blre.2022.101029_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108683","article-title":"Molecular pathology of rare bleeding disorders (RBDs) in India: a systematic review","volume":"9","author":"Kulkarni","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.blre.2022.101029_bb0045","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/hae.12554","article-title":"Characterization of an apparently synonymous F5 mutation causing aberrant splicing and factor V deficiency","volume":"21","author":"Nuzzo","year":"2015","journal-title":"Haemophilia"},{"issue":"1","key":"10.1016\/j.blre.2022.101029_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19010192","article-title":"Clinical consequences and molecular bases of low fibrinogen levels","volume":"19","author":"Neerman-Arbez","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.blre.2022.101029_bb0055","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1055\/s-0033-1349222","article-title":"Congenital fibrinogen disorders: an update","volume":"39","author":"de Moerloose","year":"2013","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.blre.2022.101029_bb0060","series-title":"Seminars in Thrombosis and Hemostasis","article-title":"Clinical features and management of congenital fibrinogen deficiencies","year":"2016"},{"issue":"10","key":"10.1016\/j.blre.2022.101029_bb0065","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1182\/blood.V99.10.3654","article-title":"Analysis of fibrinogen gamma-chain truncations shows the C-terminus, particularly gammaIle387, is essential for assembly and secretion of this multichain protein","volume":"99","author":"Okumura","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.blre.2022.101029_bb0070","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.thromres.2017.10.002","article-title":"A novel frameshift mutation in the fibrinogen \u03b3C terminal region, FGG c. 1169_1170 del AT, leading to hypofibrinogenemia","volume":"159","author":"Nagata","year":"2017","journal-title":"Thromb Res"},{"issue":"1","key":"10.1016\/j.blre.2022.101029_bb0075","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3390\/ijms19010100","article-title":"Identification of two novel fibrinogen B\u03b2 chain mutations in two Slovak families with quantitative fibrinogen disorders","volume":"19","author":"Simurda","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"11","key":"10.1016\/j.blre.2022.101029_bb0080","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1111\/jth.12714","article-title":"In vitro rescue of FGA deletion by lentiviral transduction of an afibrinogenemic patient\u2019s hepatocytes","volume":"12","author":"Stroka","year":"2014","journal-title":"J Thromb Haemost"},{"issue":"6","key":"10.1016\/j.blre.2022.101029_bb0085","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1182\/blood.V97.6.1879","article-title":"Activation of multiple cryptic donor splice sites by the common congenital afibrinogenemia mutation, FGA IVS4 + 1 G-->T","volume":"97","author":"Attanasio","year":"2001","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.blre.2022.101029_bb0090","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.thromres.2015.04.025","article-title":"Congenital hypofibrinogenemia associated with novel homozygous fibrinogen A\u03b1 and heterozygous B\u03b2 chain mutations","volume":"136","author":"Castaman","year":"2015","journal-title":"Thromb Res"},{"issue":"8","key":"10.1016\/j.blre.2022.101029_bb0095","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1111\/j.1538-7836.2005.01365.x","article-title":"Fibrinogen and fibrin structure and functions","volume":"3","author":"Mosesson","year":"2005","journal-title":"J Thromb Haemost: JTH"},{"issue":"6","key":"10.1016\/j.blre.2022.101029_bb0100","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/jth.12916","article-title":"Dysfibrinogenemia: from molecular anomalies to clinical manifestations and management","volume":"13","author":"Casini","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"7","key":"10.1016\/j.blre.2022.101029_bb0105","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1182\/blood.V92.7.2195","article-title":"Gamma-chain dysfibrinogenemias: molecular structure-function relationships of naturally occurring mutations in the gamma chain of human fibrinogen","volume":"92","author":"Cote","year":"1998","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.blre.2022.101029_bb0110","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1182\/blood-2014-06-582866","article-title":"Natural history of patients with congenital dysfibrinogenemia","volume":"125","author":"Casini","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.blre.2022.101029_bb0115","first-page":"149","article-title":"Mutations in the fibrinogen A\u03b1 gene account for the majority of cases of congenital afibrinogenemia","volume":"96","author":"Neerman-Arbez","year":"2000","journal-title":"Blood"},{"issue":"01","key":"10.1016\/j.blre.2022.101029_bb0120","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/MBC.0000000000000867","article-title":"Congenital afibrinogenemia in a patient with vascular abnormalities and a novel variant: clinical-molecular description and literature review","volume":"31","author":"Virmond","year":"2020","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.blre.2022.101029_bb0125","doi-asserted-by":"crossref","DOI":"10.1055\/s-0041-1742170","article-title":"Mutations accounting for congenital fibrinogen disorders: an update","author":"Richard","year":"2022","journal-title":"Semin Thromb Hemost"},{"issue":"6","key":"10.1016\/j.blre.2022.101029_bb0130","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/hae.12719","article-title":"Hypofibrinogenemia and liver disease: a new case of Aguadilla fibrinogen and review of the literature","volume":"21","author":"Casini","year":"2015","journal-title":"Haemophilia"},{"issue":"3","key":"10.1016\/j.blre.2022.101029_bb0135","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1055\/s-2007-994933","article-title":"Dysfibrinogenemia and thrombosis","volume":"25","author":"Mosesson","year":"1999","journal-title":"Semin Thromb Hemost"},{"issue":"5","key":"10.1016\/j.blre.2022.101029_bb0140","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/jth.13655","article-title":"Genetics, diagnosis and clinical features of congenital hypodysfibrinogenemia: a systematic literature review and report of a novel mutation","volume":"15","author":"Casini","year":"2017","journal-title":"J Thromb Haemost: JTH"},{"issue":"Suppl. 1","key":"10.1016\/j.blre.2022.101029_bb0145","first-page":"S22","article-title":"Novel point mutation in fibrinogen (Innsbruck; BbetaArg44Gly). Phenotypic differences compared to another mutation (fibrinogen Nijmegen) at the same position","volume":"35","author":"Wurtinger","year":"2015","journal-title":"Hamostaseologie"},{"key":"10.1016\/j.blre.2022.101029_bb0150","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1182\/blood-2003-07-2316","article-title":"Severe hypodysfibrinogenemia in compound heterozygotes of the fibrinogen AalphaIVS411G4T mutation and an AalphaGln328 truncation (fibrinogen Keokuk)","volume":"103","author":"Lefebvre","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.blre.2022.101029_bb0155","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1160\/TH10-03-0161","article-title":"Hypodysfibrinogenaemia due to production of mutant fibrinogen alpha-chains lacking fibrinopeptide A and polymerisation knob 'A'","volume":"104","author":"Vorjohann","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2022.101029_bb0160","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1172\/JCI106191","article-title":"Congenital dysprothrombinemia: an inherited structural disorder of human prothrombin","volume":"48","author":"Shapiro","year":"1969","journal-title":"J Clin Invest"},{"key":"10.1016\/j.blre.2022.101029_bb0165","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1055\/s-0033-1348948","article-title":"Congenital prothrombin deficiency: an update","volume":"39","author":"Lancellotti","year":"2013","journal-title":"Semin Thromb Hemost"},{"issue":"9","key":"10.1016\/j.blre.2022.101029_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045533","article-title":"Association between human prothrombin variant (T165M) and kidney stone disease","volume":"7","author":"Rungroj","year":"2012","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.blre.2022.101029_bb0175","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1182\/blood.V88.10.3698.bloodjournal88103698","article-title":"A common genetic variation in the 3\u2032-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis","volume":"88","author":"Poort","year":"1996","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.blre.2022.101029_bb0180","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1046\/j.1538-7836.2003.00393.x","article-title":"Functional characterization of transcription factor binding sites for HNF1-alpha, HNF3-beta (FOXA2), HNF4-alpha, Sp1 and Sp3 in the human prothrombin gene enhancer","volume":"1","author":"Ceelie","year":"2003","journal-title":"J Thromb Haemost"},{"issue":"28","key":"10.1016\/j.blre.2022.101029_bb0185","doi-asserted-by":"crossref","first-page":"18927","DOI":"10.1016\/S0021-9258(18)55152-8","article-title":"Characterization of a novel liver-specific enhancer in the human prothrombin gene","volume":"266","author":"Chow","year":"1991","journal-title":"J Biol Chem"},{"issue":"49","key":"10.1016\/j.blre.2022.101029_bb0190","doi-asserted-by":"crossref","first-page":"12469","DOI":"10.1021\/bi00164a025","article-title":"The human prothrombin gene: transcriptional regulation in HepG2 cells","volume":"31","author":"Bancroft","year":"1992","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.blre.2022.101029_bb0195","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1159\/000470837","article-title":"Poly-(ADP-ribose) polymerase-1 promotes prothrombin gene transcription and produces des-gamma-carboxy prothrombin in hepatocellular carcinoma","volume":"95","author":"Taniguchi","year":"2017","journal-title":"Digestion"},{"issue":"10","key":"10.1016\/j.blre.2022.101029_bb0200","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1182\/blood.V88.10.3698.bloodjournal88103698","article-title":"A common genetic variation in the 3\u2032-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis","volume":"88","author":"Poort","year":"1996","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.blre.2022.101029_bb0205","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1046\/j.1365-2141.2002.03624.x","article-title":"Prothrombin A19911G and G20210A polymorphisms\u2019 role in thrombosis","volume":"118","author":"P\u00e9rez-Ceballos","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2022.101029_bb0210","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000040854","article-title":"Prevalence of the G20210 a polymorphism in the 3\u2032-untranslated region of the prothrombin gene in different human populations","volume":"100","author":"Franco","year":"1998","journal-title":"Acta Haematol"},{"key":"10.1016\/j.blre.2022.101029_bb0215","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1055\/s-0037-1615049","article-title":"Geographic distribution of the 20210 G to A prothrombin variant","volume":"79","author":"Rosendaal","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2022.101029_bb0220","doi-asserted-by":"crossref","first-page":"12","DOI":"10.7754\/Clin.Lab.2019.190603","article-title":"A rare prothrombin gene mutation C20209T in a south African patient with pulmonary embolism in pregnancy: a case study and systematic review","volume":"65","author":"Skhosana","year":"2019","journal-title":"Clin Lab"},{"key":"10.1016\/j.blre.2022.101029_bb0225","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1055\/s-0039-1687906","article-title":"A comprehensive overview of coagulation factor V and congenital factor V deficiency","volume":"45","author":"Tabibian","year":"2019","journal-title":"Semin Thromb Hemost"},{"issue":"05","key":"10.1016\/j.blre.2022.101029_bb0230","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1182\/blood.V86.5.1820.bloodjournal8651820","article-title":"Factor VNew Brunswick: Ala221-to-Val substitution results in reduced cofactor activity","volume":"86","author":"Murray","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.blre.2022.101029_bb0235","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1021\/bi00130a007","article-title":"Structure of the gene for human coagulation factor V","volume":"31","author":"Cripe","year":"1992","journal-title":"Biochemistry"},{"issue":"08","key":"10.1016\/j.blre.2022.101029_bb0240","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.biocel.2003.08.002","article-title":"Coagulation factor V","volume":"36","author":"Duga","year":"2004","journal-title":"Int J Biochem Cell Biol"},{"issue":"19","key":"10.1016\/j.blre.2022.101029_bb0245","doi-asserted-by":"crossref","first-page":"19580","DOI":"10.1074\/jbc.M400727200","article-title":"The factor V activation paradox","volume":"279","author":"Orfeo","year":"2004","journal-title":"J Biol Chem"},{"issue":"02","key":"10.1016\/j.blre.2022.101029_bb0250","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/hae.12554","article-title":"Characterization of an apparently synonymous F5 mutation causing aberrant splicing and factor V deficiency","volume":"21","author":"Nuzzo","year":"2015","journal-title":"Haemophilia"},{"key":"10.1016\/j.blre.2022.101029_bb0255","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1160\/TH11-03-0149","article-title":"Identification of the first Alu-mediated large deletion involving the F5 gene in a compound heterozygous patient with severe factor V deficiency","volume":"106","author":"Guella","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2022.101029_bb0260","first-page":"575","article-title":"Congenital factor V deficiency (parahemophilia) with true hemophilia in two brothers","volume":"58","author":"Oeri","year":"1954","journal-title":"Bibl Paediatr"},{"issue":"7","key":"10.1016\/j.blre.2022.101029_bb0265","first-page":"472","article-title":"Combined factor V and factor VIII deficiency: a report of a case, genetic analysis, and response to desmopressin acetate","volume":"10","author":"Chapin","year":"2012","journal-title":"Clin Adv Hematol Oncol"},{"key":"10.1016\/j.blre.2022.101029_bb0270","series-title":"Congenital Bleeding Disorders","first-page":"219","article-title":"Multiple coagulation factor deficiency","author":"Hosseini","year":"2018"},{"issue":"5","key":"10.1016\/j.blre.2022.101029_bb0275","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1182\/blood-2005-09-3620","article-title":"Combined deficiency of factor V and factor VIII is due to mutations in either LMAN1 or MCFD2","volume":"107","author":"Zhang","year":"2006","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.blre.2022.101029_bb0280","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1182\/blood.V93.7.2253","article-title":"Molecular analysis of the ERGIC-53 gene in 35 families with combined factor V-factor VIII deficiency","volume":"93","author":"Neerman-Arbez","year":"1999","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.blre.2022.101029_bb0285","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1182\/blood-2009-09-241877","article-title":"EF-hand domains of MCFD2 mediate interactions with both LMAN1 and coagulation factor V or VIII","volume":"115","author":"Zheng","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.blre.2022.101029_bb0290","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.1182\/blood-2007-10-113951","article-title":"Genotype-phenotype correlation in combined deficiency of factor V and factor VIII","volume":"111","author":"Zhang","year":"2008","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.blre.2022.101029_bb0295","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1055\/s-0033-1349223","article-title":"Combined deficiency of coagulation factors V and VIII: an update","volume":"39","author":"Zheng","year":"2013","journal-title":"Semin Thromb Hemost"},{"issue":"3","key":"10.1016\/j.blre.2022.101029_bb0300","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1182\/blood-2007-09-112854","article-title":"Deletion of 3 residues from the C-terminus of MCFD2 affects binding to ERGIC-53 and causes combined factor V and factor VIII deficiency","volume":"111","author":"Nyfeler","year":"2008","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.blre.2022.101029_bb0305","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1056\/NEJM198211043071907","article-title":"Combined factor V and factor VIII deficiency among non-Ashkenazi Jews","volume":"307","author":"Seligsohn","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2022.101029_bb0310","series-title":"Seminars in Thrombosis and Hemostasis","article-title":"Vitamin K\u2013dependent coagulation factors deficiency","author":"Brenner","year":"2009"},{"issue":"8","key":"10.1016\/j.blre.2022.101029_bb0315","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.3324\/haematol.2019.229047","article-title":"Vitamin K-dependent carboxylation of coagulation factors: insights from a cell-based functional study","volume":"105","author":"Hao","year":"2020","journal-title":"haematologica"},{"issue":"2","key":"10.1016\/j.blre.2022.101029_bb0320","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3390\/ijms18020240","article-title":"GGCX-associated phenotypes: an overview in search of genotype-phenotype correlations","volume":"18","author":"De Vilder","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"5038","key":"10.1016\/j.blre.2022.101029_bb0325","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1126\/science.1749935","article-title":"Cloning and expression of the cDNA for human \u03b3-glutamyl carboxylase","volume":"254","author":"Wu","year":"1991","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.blre.2022.101029_bb0330","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1182\/blood.2020006329","article-title":"\u03b3-Glutamyl carboxylase mutations differentially affect the biological function of vitamin K\u2013dependent proteins","volume":"137","author":"Hao","year":"2021","journal-title":"Blood"},{"issue":"3\u20134","key":"10.1016\/j.blre.2022.101029_bb0335","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1089\/ars.2006.8.347","article-title":"Vitamin K epoxide reductase complex subunit 1 (VKORC1): the key protein of the vitamin K cycle","volume":"8","author":"Oldenburg","year":"2006","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"10.1016\/j.blre.2022.101029_bb0340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-5-21","article-title":"Hereditary combined deficiency of the vitamin K-dependent clotting factors","volume":"5","author":"Napolitano","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.blre.2022.101029_bb0345","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1182\/blood-2013-12-545988","article-title":"The Arg98Trp mutation in human VKORC1 causing VKCFD2 disrupts a di-arginine-based ER retention motif","volume":"124","author":"Czogalla","year":"2014","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.blre.2022.101029_bb0350","doi-asserted-by":"crossref","DOI":"10.3390\/jcm6040038","article-title":"Factor VII deficiency: clinical phenotype, genotype and therapy","volume":"6","author":"Napolitano","year":"2017","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.blre.2022.101029_bb0355","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-2516.2008.01910.x","article-title":"Factor VII deficiency: clinical manifestation of 717 subjects from Europe and Latin America with mutations in the factor 7 gene","volume":"15","author":"Herrmann","year":"2009","journal-title":"Haemophilia Off J World Fed Hemophilia"},{"issue":"15","key":"10.1016\/j.blre.2022.101029_bb0360","doi-asserted-by":"crossref","first-page":"5158","DOI":"10.1073\/pnas.84.15.5158","article-title":"Nucleotide sequence of the gene coding for human factor VII, a vitamin K-dependent protein participating in blood coagulation","volume":"84","author":"O\u2019Hara","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.blre.2022.101029_bb0365","series-title":"The EAHAD Blood Coagulation Factor VII Variant Database","first-page":"1209","volume":"41","author":"Giansily-Blaizot","year":"2020"},{"issue":"3","key":"10.1016\/j.blre.2022.101029_bb0370","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1160\/TH04-10-0650","article-title":"Clinical phenotypes and factor VII genotype in congenital factor VII deficiency","volume":"93","author":"Mariani","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2022.101029_bb0375","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/j.1365-2516.2008.01856.x","article-title":"Diagnosis and treatment of inherited factor X deficiency","volume":"14","author":"Brown","year":"2008","journal-title":"Haemophilia"},{"key":"10.1016\/j.blre.2022.101029_bb0380","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2516.2006.01303.x","article-title":"Factor X deficiency: clinical manifestation of 102 subjects from Europe and Latin America with mutations in the factor 10 gene","volume":"12","author":"Herrmann","year":"2006","journal-title":"Haemophilia"},{"issue":"12","key":"10.1016\/j.blre.2022.101029_bb0385","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1073\/pnas.81.12.3699","article-title":"Characterization of a cDNA coding for human factor X","volume":"81","author":"Leytus","year":"1984","journal-title":"Proc Natl Acad Sci"},{"issue":"5","key":"10.1016\/j.blre.2022.101029_bb0390","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1600-0609.2007.00836.x","article-title":"Recurrence of a Phe31Ser mutation in the Gla domain of blood coagulation factor X, in unrelated Algerian families: a founder effect?","volume":"78","author":"Akhavan","year":"2007","journal-title":"Eur J Haematol"},{"issue":"4","key":"10.1016\/j.blre.2022.101029_bb0395","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s12185-014-1643-6","article-title":"Factor X M402T: a homozygous missense mutation identified as the cause of cross-reacting material-reduced deficiency","volume":"100","author":"Chikasawa","year":"2014","journal-title":"Int J Hematol"},{"key":"10.1016\/j.blre.2022.101029_bb0400","series-title":"Seminars in Thrombosis and Hemostasis","article-title":"Factor X deficiency","author":"Menegatti","year":"2009"},{"key":"10.1016\/j.blre.2022.101029_bb0405","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1073\/pnas.81.12.3699","article-title":"Characterization of a cDNA coding for human factor X","volume":"81","author":"Leytus","year":"1984","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.blre.2022.101029_bb0410","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1182\/blood.V97.4.946","article-title":"Regulation of human coagulation factor X gene expression by GATA-4 and the Sp family of transcription factors","volume":"97","author":"Hung","year":"2001","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.blre.2022.101029_bb0415","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1074\/jbc.271.4.2323","article-title":"Liver-enriched transcription factor HNF-4 and ubiquitous factor NF-Y are critical for expression of blood coagulation factor X","volume":"271","author":"Hung","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.blre.2022.101029_bb0420","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.thromres.2015.12.009","article-title":"A novel Ala275Val mutation in factor X gene influences its structural compatibility and impairs intracellular trafficking and coagulant activity","volume":"138","author":"Sun","year":"2016","journal-title":"Thromb Res"},{"issue":"1","key":"10.1016\/j.blre.2022.101029_bb0425","first-page":"140","article-title":"Functional consequences of the Ser334\u2192 Pro mutation in a human factor X variant (factor XMarseille)","volume":"234","author":"Bezeaud","year":"1995","journal-title":"FEBS J"},{"issue":"1","key":"10.1016\/j.blre.2022.101029_bb0430","first-page":"140","article-title":"Functional consequences of the Ser334\u2192 Pro mutation in a human factor X variant (factor XMarseille)","volume":"234","author":"Bezeaud","year":"1995","journal-title":"FEBS J"},{"issue":"6","key":"10.1016\/j.blre.2022.101029_bb0435","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/MBC.0000000000000305","article-title":"Neonatal onset of congenital factor X deficiency: a description of two novel mutations with 6-year follow-up","volume":"26","author":"Corsini","year":"2015","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"2","key":"10.1016\/j.blre.2022.101029_bb0440","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3324\/haematol.11746","article-title":"Factor XDebrecen: Gly204Arg mutation in factor X causes the synthesis of a non-secretable protein and severe factor X deficiency","volume":"93","author":"Bereczky","year":"2008","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.blre.2022.101029_bb0445","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/MBC.0000000000000435","article-title":"Spectrum of factor X gene mutations in Iranian patients with congenital factor X deficiency","volume":"27","author":"Dorgalaleh","year":"2016","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"20","key":"10.1016\/j.blre.2022.101029_bb0450","doi-asserted-by":"crossref","first-page":"11982","DOI":"10.1016\/S0021-9258(19)38497-2","article-title":"Molecular defect (Gla+ 14----Lys) and its functional consequences in a hereditary factor X deficiency (factor X\u201c Vorarlberg\u201d)","volume":"265","author":"Watzke","year":"1990","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.blre.2022.101029_bb0455","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/00001721-199803000-00005","article-title":"Factor X Frankfurt I: molecular and functional characterization of a hereditary factor X deficiency (Gla+ 25 to Lys)","volume":"9","author":"N\u00f6bauer-Huhmann","year":"1998","journal-title":"Blood Coagul Fibrinolysis Int J Haemost Thromb"},{"issue":"04","key":"10.1016\/j.blre.2022.101029_bb0460","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1160\/TH06-09-0532","article-title":"Analysis of the novel factor X gene mutation Glu51Lys in two families with factor X-Riyadh anomaly","volume":"97","author":"Al-Hilali","year":"2007","journal-title":"Thromb Haemost"},{"issue":"5","key":"10.1016\/j.blre.2022.101029_bb0465","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00277-003-0803-1","article-title":"Two novel factor X gene mutations in a Chinese family with factor X deficiency","volume":"83","author":"Au","year":"2004","journal-title":"Ann Hematol"},{"key":"10.1016\/j.blre.2022.101029_bb0470","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3181\/00379727-82-20057","article-title":"New hemophilia-like disease caused by deficiency of a third plasma thromboplastin factor","volume":"82","author":"Rosenthal","year":"1953","journal-title":"Proc Soc Exp Biol Med"},{"issue":"4","key":"10.1016\/j.blre.2022.101029_bb0475","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0950-3536(89)80046-0","article-title":"The molecular genetics of factor XI deficiency","volume":"2","author":"Asakai","year":"1989","journal-title":"Baill\u00e8res Clin Haematol"},{"key":"10.1016\/j.blre.2022.101029_bb0480","doi-asserted-by":"crossref","first-page":"7221","DOI":"10.1021\/bi00397a004","article-title":"Organization of the gene for human factor XI","volume":"26","author":"Asakai","year":"1987","journal-title":"Biochemistry"},{"issue":"6","key":"10.1016\/j.blre.2022.101029_bb0485","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1055\/s-0033-1353420","article-title":"Congenital factor XI deficiency: an update","volume":"39","author":"Duga","year":"2013","journal-title":"Semin Thromb Hemost"},{"issue":"8","key":"10.1016\/j.blre.2022.101029_bb0490","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/MBC.0000000000000862","article-title":"Congenital factor XI deficiency, complete genotype and phenotype of two Iranian families","volume":"30","author":"Dorgalaleh","year":"2019","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.blre.2022.101029_bb0495","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/humu.9439","article-title":"Spectrum of factor XI (F11) mutations in the UK population \u2013 116 index cases and 140 mutations","volume":"27","author":"Mitchell","year":"2006","journal-title":"Hum Mutat"},{"key":"10.1016\/j.blre.2022.101029_bb0500","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/j.1538-7836.2004.00723.x","article-title":"A common ancestral mutation (C128X) occurring in 11 non-Jewish families from the UK with factor XI deficiency","volume":"2","author":"Bolton-Maggs","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2022.101029_bb0505","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bcmd.2016.01.004","article-title":"Clinical manifestations and mutation spectrum of 57 subjects with congenital factor XI deficiency in China","volume":"58","author":"Shao","year":"2016","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.blre.2022.101029_bb0510","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.thromres.2016.09.022","article-title":"Clinical and molecular epidemiology of factor XI deficiency in India","volume":"147","author":"Kawankar","year":"2016","journal-title":"Thromb Res"},{"issue":"1","key":"10.1016\/j.blre.2022.101029_bb0515","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/hae.12257","article-title":"The spectrum of factor XI deficiency in Italy","volume":"20","author":"Castaman","year":"2014","journal-title":"Haemophilia"},{"issue":"8","key":"10.1016\/j.blre.2022.101029_bb0520","first-page":"1149","article-title":"Factor XI deficiency: identification of six novel missense mutations (P23L, P69T, C92G, E243D, W497C and E547K)","volume":"90","author":"Qu\u00e9lin","year":"2005","journal-title":"Haematologica"},{"issue":"11","key":"10.1016\/j.blre.2022.101029_bb0525","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1182\/blood.V106.11.1788.1788","article-title":"A G> a transition in the non-coding exon 1 of the factor XI gene as the cause of factor XI deficiency in three Afro-Caribbean patients","volume":"106","author":"Mitchell","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.blre.2022.101029_bb0530","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.ijcard.2014.10.014","article-title":"Factor XI rs2036914 gene polymorphism and occurrence of adverse events after percutaneous coronary intervention. A prospective evaluation","volume":"177","author":"Campo","year":"2014","journal-title":"Int J Cardiol"},{"issue":"7","key":"10.1016\/j.blre.2022.101029_bb0535","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1080\/01443615.2017.1312303","article-title":"Factor 11 single-nucleotide variants in women with heavy menstrual bleeding","volume":"37","author":"Wiewel-Verschueren","year":"2017","journal-title":"J Obstet Gynaecol"},{"key":"10.1016\/j.blre.2022.101029_bb0540","series-title":"Congenital Bleeding Disorders","first-page":"291","article-title":"Congenital factor XI deficiency","author":"Tabatabaei","year":"2018"},{"issue":"1","key":"10.1016\/j.blre.2022.101029_bb0545","first-page":"105","article-title":"Molecular genetic analysis of the F11 gene in 14 Turkish patients with factor XI deficiency: identification of novel and recurrent mutations and their inheritance within families","volume":"16","author":"Colakoglu","year":"2018","journal-title":"Blood Transfus"},{"issue":"1","key":"10.1016\/j.blre.2022.101029_bb0550","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1182\/blood-2003-10-3530","article-title":"Dominant factor XI deficiency caused by mutations in the factor XI catalytic domain","volume":"104","author":"Kravtsov","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.blre.2022.101029_bb0555","series-title":"One of the Two Common Mutations Causing Factor XI Deficiency in Ashkenazi Jews (Type II) is Also Prevalent in Iraqi Jews, Who Represent the Ancient Gene Pool of Jews.","first-page":"429","author":"Shpilberg","year":"1995"},{"key":"10.1016\/j.blre.2022.101029_bb0560","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1056\/NEJM199107183250303","article-title":"Factor XI deficiency in Ashkenazi Jews in Israel","volume":"325","author":"Asakai","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2022.101029_bb0565","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1160\/TH11-06-0415","article-title":"Revisiting the molecular epidemiology of factor XI deficiency: nine new mutations and an original large 4qTer deletion in western Brittany (France)","volume":"107","author":"Gueguen","year":"2012","journal-title":"Thromb Haemost"},{"issue":"14","key":"10.1016\/j.blre.2022.101029_bb0570","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1097\/00001721-200306001-00014","article-title":"Factor XI deficiency-from molecular genetics to clinical management","volume":"1","author":"O\u2019Connell","year":"2003","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"Suppl. 1","key":"10.1016\/j.blre.2022.101029_bb0575","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1538-7836.2009.03395.x","article-title":"Factor XI deficiency in humans","volume":"7","author":"Seligsohn","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"3","key":"10.1016\/j.blre.2022.101029_bb0580","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/os.12262","article-title":"F11 rs2289252T and rs2036914C polymorphisms increase the activity of factor XI in post-trauma patients with fractures despite thromboprophylaxis","volume":"8","author":"Song","year":"2016","journal-title":"Orthop Surg"},{"issue":"6","key":"10.1016\/j.blre.2022.101029_bb0585","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.hoc.2021.07.012","article-title":"Factor XI deficiency","volume":"35","author":"Lewandowska","year":"2021","journal-title":"Hematol Oncol Clin North Am"},{"issue":"12","key":"10.1016\/j.blre.2022.101029_bb0590","doi-asserted-by":"crossref","first-page":"4783","DOI":"10.1182\/blood-2002-09-2794","article-title":"Prevalence, causes, and characterization of factor XI inhibitors in patients with inherited factor XI deficiency","volume":"101","author":"Salomon","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.blre.2022.101029_bb0595","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.blre.2016.06.002","article-title":"Blood coagulation factor XIII and factor XIII deficiency","volume":"30","author":"Dorgalaleh","year":"2016","journal-title":"Blood Rev"},{"key":"10.1016\/j.blre.2022.101029_bb0600","series-title":"Structural and Functional Characterization of Human Coagulation Factor XIII","author":"Singh","year":"2020"},{"issue":"22","key":"10.1016\/j.blre.2022.101029_bb0605","doi-asserted-by":"crossref","first-page":"6900","DOI":"10.1021\/bi00370a025","article-title":"Amino acid sequence of the a subunit of human factor XIII","volume":"25","author":"Ichinose","year":"1986","journal-title":"Biochemistry"},{"issue":"8","key":"10.1016\/j.blre.2022.101029_bb0610","doi-asserted-by":"crossref","first-page":"4917","DOI":"10.1074\/jbc.274.8.4917","article-title":"Identification of the calcium binding site and a novel ytterbium site in blood coagulation factor XIII by X-ray crystallography","volume":"274","author":"Fox","year":"1999","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.blre.2022.101029_bb0615","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1160\/TH06-08-0458","article-title":"Factor XIII activation peptide is released into plasma upon cleavage by thrombin and shows a different structure compared to its bound form","volume":"97","author":"Schroeder","year":"2007","journal-title":"Thromb Haemost"},{"issue":"8","key":"10.1016\/j.blre.2022.101029_bb0620","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1111\/jth.13035","article-title":"The activation peptide of coagulation factor XIII is vital for its expression and stability","volume":"13","author":"Handrkova","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"33","key":"10.1016\/j.blre.2022.101029_bb0625","doi-asserted-by":"crossref","first-page":"8656","DOI":"10.1021\/bi8006143","article-title":"Sushi domains in the B subunit of Factor XIII responsible for oligomer assembly\u2020","volume":"47","author":"Souri","year":"2008","journal-title":"Biochemistry"},{"issue":"16","key":"10.1016\/j.blre.2022.101029_bb0630","doi-asserted-by":"crossref","first-page":"5829","DOI":"10.1073\/pnas.85.16.5829","article-title":"Characterization of the gene for the a subunit of human factor XIII (plasma transglutaminase), a blood coagulation factor","volume":"85","author":"Ichinose","year":"1988","journal-title":"Proc Natl Acad Sci"},{"issue":"5","key":"10.1016\/j.blre.2022.101029_bb0635","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0049-3848(99)00023-7","article-title":"Blood coagulation factor XIII: structure and function","volume":"94","author":"Muszbek","year":"1999","journal-title":"Thromb Res"},{"issue":"3","key":"10.1016\/j.blre.2022.101029_bb0640","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1152\/physrev.00016.2010","article-title":"Factor XIII: a coagulation factor with multiple plasmatic and cellular functions","volume":"91","author":"Muszbek","year":"2011","journal-title":"Physiol Rev"},{"issue":"4","key":"10.1016\/j.blre.2022.101029_bb0645","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1365-2516.2010.02207.x","article-title":"Mutations affecting disulphide bonds contribute to a fairly common prevalence of F13B gene defects: results of a genetic study in 14 families with factor XIII B deficiency","volume":"16","author":"Ivaskevicius","year":"2010","journal-title":"Haemophilia"},{"issue":"3","key":"10.1016\/j.blre.2022.101029_bb0650","first-page":"348","article-title":"Genetic polymorphism of the B subunit of human coagulation factor XIII","volume":"32","author":"Board","year":"1980","journal-title":"Am J Hum Genet"},{"issue":"19","key":"10.1016\/j.blre.2022.101029_bb0655","doi-asserted-by":"crossref","first-page":"12027","DOI":"10.1074\/jbc.M114.608570","article-title":"The non-catalytic B subunit of coagulation factor XIII accelerates fibrin cross-linking","volume":"290","author":"Souri","year":"2015","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.blre.2022.101029_bb0660","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood.V80.4.937.937","article-title":"Identification of a point mutation in factor XIII A subunit deficiency","volume":"80","author":"Board","year":"1992","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.blre.2022.101029_bb0665","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1172\/JCI115864","article-title":"Deficiency of coagulation factor XIII A subunit caused by the dinucleotide deletion at the 5\u2032 end of exon III","volume":"90","author":"Kamura","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.blre.2022.101029_bb0670","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00277-009-0863-y","article-title":"Congenital factor XIII deficiency caused by two mutations in eight Tunisian families: molecular confirmation of a founder effect","volume":"89","author":"Louhichi","year":"2010","journal-title":"Ann Hematol"},{"issue":"2","key":"10.1016\/j.blre.2022.101029_bb0675","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1182\/blood.V92.2.481","article-title":"A novel Asn344 deletion in the core domain of coagulation factor XIII A subunit: its effects on protein structure and function","volume":"92","author":"Kangsadalampai","year":"1998","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.blre.2022.101029_bb0680","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/01.mbc.0000214707.65750.f4","article-title":"Effect of four missense mutations in the factor XIII A-subunit gene on protein stability: studies with recombinant proteins","volume":"17","author":"Vysokovsky","year":"2006","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"1","key":"10.1016\/j.blre.2022.101029_bb0685","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1160\/TH05-06-0388","article-title":"Characterisation of six novel A-subunit mutations leading to congenital factor XIII deficiency and molecular analysis of the first diagnosed patient with this rare bleeding disorder","volume":"95","author":"Schroeder","year":"2006","journal-title":"Thromb Haemost"},{"issue":"2","key":"10.1016\/j.blre.2022.101029_bb0690","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1177\/1076029616680473","article-title":"Molecular basis of congenital factor XIII deficiency in Iran","volume":"24","author":"Dorgalaleh","year":"2018","journal-title":"Clin Appl Thromb Hemost"},{"issue":"1","key":"10.1016\/j.blre.2022.101029_bb0695","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1160\/TH05-06-0388","article-title":"Characterisation of six novel Asubunit mutations leading to congenital factor XIII deficiency and molecular analysis of the first diagnosed patient with this rare bleeding disorder","volume":"95","author":"Schroeder","year":"2006","journal-title":"Thromb Haemost"},{"issue":"4","key":"10.1016\/j.blre.2022.101029_bb0700","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1365-2516.2010.02207.x","article-title":"Mutations affecting disulphide bonds contribute to a fairly common prevalence of F13B gene defects: results of a genetic study in 14 families with factor XIII B deficiency","volume":"16","author":"Ivaskevicius","year":"2010","journal-title":"Haemophilia"},{"issue":"2","key":"10.1016\/j.blre.2022.101029_bb0705","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1055\/s-0037-1615173","article-title":"A founder effect is proposed for factor XIII B subunit deficiency caused by the insertion of triplet AAC in exon III encoding the second Sushi domain","volume":"80","author":"Souri","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2022.101029_bb0710","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s12881-020-01111-0","article-title":"A novel Cys328-terminator mutant implicated in severe coagulation factor XIII deficiency: a case report","volume":"21","author":"Cai","year":"2020","journal-title":"BMC Med Genet"},{"issue":"3","key":"10.1016\/j.blre.2022.101029_bb0715","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1365-2141.1990.00282.x-i1","article-title":"A familial factor XIII subunit B deficiency","volume":"74","author":"Saito","year":"1990","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2022.101029_bb0720","series-title":"Identification of Novel and Recurrent Mutations in F13B Gene Leading to FXIII Deficiency","author":"Iva\u0161kevi\u010dius","year":"2017"},{"key":"10.1016\/j.blre.2022.101029_bb0725","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.3390\/ijms20081956","article-title":"Disruption of structural disulfides of coagulation FXIII-B subunit; functional implications for a rare bleeding disorder","volume":"20","author":"Singh","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.blre.2022.101029_bb0730","first-page":"116","article-title":"Genetic polymorphism of the A subunit of human coagulation factor XIII","volume":"31","author":"Board","year":"1979","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.blre.2022.101029_bb0735","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12881-018-0674-x","article-title":"Factor XIII polymorphism and risk of aneurysmal subarachnoid haemorrhage in a south Indian population","volume":"19","author":"Suvatha","year":"2018","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.blre.2022.101029_bb0740","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1055\/s-0037-1614073","article-title":"Effect of Val34Leu polymorphism on the activation of the coagulation factor XIII-A","volume":"84","author":"Wartiovaara","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2022.101029_bb0745","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1253\/circj.70.239","article-title":"The association between factor XIII Val34Leu polymorphism and early myocardial infarction","volume":"70","author":"Hancer","year":"2006","journal-title":"Circ J"},{"issue":"3","key":"10.1016\/j.blre.2022.101029_bb0750","first-page":"348","article-title":"Genetic polymorphism of the B subunit of human coagulation factor XIII","volume":"32","author":"Board","year":"1980","journal-title":"Am J Hum Genet"},{"issue":"11","key":"10.1016\/j.blre.2022.101029_bb0755","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1111\/j.1538-7836.2005.01624.x","article-title":"A novel polymorphism in the factor XIII B-subunit (His95Arg): relationship to subunit dissociation and venous thrombosis","volume":"3","author":"Komanasin","year":"2005","journal-title":"J Thromb Haemost"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X22001035?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X22001035?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T20:28:40Z","timestamp":1759436920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X22001035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":151,"alternative-id":["S0268960X22001035"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2022.101029","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular basis of rare congenital bleeding disorders","name":"articletitle","label":"Article Title"},{"value":"Blood Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.blre.2022.101029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101029"}}